Compounds > 2-(4-morpholinoanilino)-6-cyclohexylaminopurine
Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and 6-bromoindirubin-3'-oxime

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with 6-bromoindirubin-3'-oxime in 1 studies

Compound Research Comparison

Studies
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Trials
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Recent Studies (post-2010)
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Studies
(6-bromoindirubin-3'-oxime)		Trials
(6-bromoindirubin-3'-oxime)		Recent Studies (post-2010) (6-bromoindirubin-3'-oxime)
850621710114

Protein Interaction Comparison

ProteinTaxonomy2-(4-morpholinoanilino)-6-cyclohexylaminopurine (IC50)6-bromoindirubin-3'-oxime (IC50)
SUMO1/sentrin specific peptidase 7Homo sapiens (human)5.6
Glycogen synthase kinase-3 beta Sus scrofa (pig)0.005
[Tau protein] kinase Sus scrofa (pig)0.005
caspase-3 isoform a preproproteinHomo sapiens (human)64.3
matrix metalloproteinase-14 preproproteinHomo sapiens (human)5.335
melanocortin receptor 4Homo sapiens (human)6.37
Aurora kinase AHomo sapiens (human)0.6
Casein kinase I isoform alphaSus scrofa (pig)1.2
Cyclin-T1Homo sapiens (human)0.45
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.32
Cyclin-dependent kinase 1Homo sapiens (human)0.3117
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)2.0333
Cyclin-dependent kinase 4Homo sapiens (human)0.527
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.3075
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)0.6
Cyclin-A2Homo sapiens (human)0.069
G1/S-specific cyclin-D1Homo sapiens (human)0.527
G1/S-specific cyclin-E1Homo sapiens (human)0.014
Cyclin-dependent kinase 2Homo sapiens (human)0.0415
Dual specificity protein kinase CLK1Homo sapiens (human)2.1
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.062
Glycogen synthase kinase-3 betaHomo sapiens (human)0.3298
Cyclin-dependent kinase 7Homo sapiens (human)3.5
Cyclin-dependent kinase 9Homo sapiens (human)0.45
Cyclin-HHomo sapiens (human)3.5
CDK-activating kinase assembly factor MAT1Homo sapiens (human)3.5
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.078
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.052
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.0746
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)1.5
Dual specificity tyrosine-phosphorylation-regulated kinase 1ARattus norvegicus (Norway rat)1.11
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.32
Dual specificity tyrosine-phosphorylation-regulated kinase 2Homo sapiens (human)2.1
Aurora kinase BHomo sapiens (human)0.9
Bile acid receptorHomo sapiens (human)3.4
Aurora kinase CHomo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, DW; Kim, WH; Shen, H; Williams, DR1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and 6-bromoindirubin-3'-oxime

ArticleYear
Some leopards can change their spots: potential repositioning of stem cell reprogramming compounds as anti-cancer agents.
    Cell biology and toxicology, 2016, Volume: 32, Issue:3

    Topics: Animals; Antineoplastic Agents; Cellular Reprogramming; Drug Repositioning; Humans; Indoles; Morpholines; Oximes; Purines; Stem Cells; Zebrafish

2016